Reports

The Oregon Prescription Drug Affordability Board is pleased to provide its first report to the Oregon Legislature as required by Senate Bill 844, the board's founding legislation. The 50-page report has these components:

• Executive Summary, Page 4
  
• Section 5, with five recommendations for making prescription drugs more affordable for Oregonians, Page 9 
  
• Generic Drugs: How patents, shortages, contracts, and biosimilars affect the availability and cost, Page 12
  
• The Prescription Drug Distribution and Payment System: Understanding the complex process of getting medications from the factory to patients, Page 24 
  
• Glossary, Page 50
  

View the 2022 inaugural report